Published in Gene Therapy Weekly, March 25th, 2004
The drug discovery collaboration is focused on Bionomics' proprietary ion channel targets and animal models, which form the basis of Bionomics' R&D Start Grant-funded drug discovery program. The focus of the drug discovery collaboration will be to identify new lead molecules for the treatment of central nervous system (CNS) disorders including epilepsy and anxiety.
"We are pleased to be partnering with WEHI and look forward to working with WEHI's compound library...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.